Hepatic growth factor receptor is the met proto-oncogene
CA 2176620 C · Owner: Faletto, Donna · Inventors: Vande Woude, George F.; Faletto, Donna; Rubin, Jeffrey S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a complex comprising hepatocyte growth factor (HGF) and met proto-oncogene protein. The present invention also relates to methods for detecting the presence of HGF ligand met , proto-oncogene receptor and methods for isolating either the ligand or receptor or complex comprising both. The present invention further relates to methods of diagnostic proliferative disorders and diseases such as hepatitis or hepatocarcino-genesis by detecting these ligand-receptor pairs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 15, 1992 and granted April 24, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 15, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 15, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.